ARCHIVES

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

IOM Panel Suggest Ways To Fund More Training, Construction

November 9, 1990

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned

October 31, 1986

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers

April 27, 2007